Scientist.com Announces Fourth Podcast in Mendelspod Series on Human Biospecimen Quality and Regulations
Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced the successful conclusion of a four-part podcast series on human biological samples and biobanking. The four guests offered thoughtful insights and ideas from an academic, pharmaceutical and small business perspective. The episodes were hosted by Mendelspod , one of the life science industry’s leading podcasts.
“This is the second time we’ve covered human biospecimen quality and governance on this show, which tells me that people are interested and looking for answers,” said Theral Timpson, Host, Producer and Co-Founder of Mendelspod. “What Scientist.com is doing—offering a self-regulatory solution within the life sciences—is a practical first step toward filling an important gap.”
The series featured experts in biospecimen regulation, biobanking and compliance, including Carolyn Compton, PhD, Chief Medical Officer of the National Biomarker Development Alliance and ASU professor; Shannon McCall, PhD, Director of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University; Kirstin Goldring, PhD, Counselor at the European Society for Biopreservation and Biobanking and member of ISBER; and Matt McLoughlin, Vice President of Compliance at Scientist.com. Topics covered ranged from the sustainability of biobanks to a discussion of COMPLi™ —Scientist.com’s proprietary compliance framework for overseeing the acquisition of human biological samples for research.
“It was an honor to be included amongst a group of such distinguished and knowledgeable speakers on the topic of human biospecimen quality and biobanking,” commented McLoughlin. “Forums like these raise awareness regarding the sustainability of biobanks and help us create a more standardized set of rules governing human biospecimen acquisition.”
All podcasts are accessible free of charge at https://mendelspod.com/ .
Scientist.com is the world's leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo, among others. Visit scientist.com to learn more.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
XINHUANET25.5.2019 20:22:13 CEST | Pressemeddelelse
XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival
PA-KNOPP-BIOSCIENCES24.5.2019 16:02:05 CEST | Pressemeddelelse
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference
NIPA24.5.2019 12:22:09 CEST | Pressemeddelelse
Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge
IPSEN24.5.2019 07:02:07 CEST | Pressemeddelelse
New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting
POSIFLEX-GROUP24.5.2019 03:02:05 CEST | Pressemeddelelse
The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 2019
CA-ANDERSEN-TAX23.5.2019 22:49:12 CEST | Pressemeddelelse
Andersen Global udvider lokaliteter i Storbritannien
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum